Ki-67 is a prognostic marker for hormone receptor positive tumors.

Maria Eva Perez-LopezJ García-GómezM T AlvesA ParadelaJ García-MataT García-Caballero

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2016)

Ki-67 represents an additional predictor of survival in Luminal B node negative breast cancer. Conversely, neither Progesterone-receptor nor HER2 status proved prognostic significance in this group in our study.

Keyphrases

neoadjuvant chemotherapy
lymph node
radiation therapy
young adults
binding protein
rectal cancer
childhood cancer